Home LiteratureArticle Details
PMID: 8393480 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

T cell receptor interaction with peptide/major histocompatibility complex (MHC) and superantigen/MHC ligands is dominated by antigen.

The Journal of experimental medicine ·Vol. 178 ·No. 2 ·1993-08-01 ·Pages 713-22

Ehrich EW, Devaux B, Rock EP, Jorgensen JL, Davis MM, Chien YH

Abstract

While recent evidence strongly suggests that the third complementarity determining regions (CDR3s) of T cell receptors (TCRs) directly contact antigenic peptides bound to major histocompatibility complex (MHC) molecules, the nature of other TCR contact(s) is less clear. Here we probe the extent to which different antigens can affect this interaction by comparing the responses of T cells bearing structurally related TCRs to cytochrome c peptides and staphylococcal enterotoxin A (SEA) presented by 13 mutant antigen-presenting cell (APC) lines. Each APC expresses a class II MHC molecule (I-Ek) with a single substitution of an amino acid residue predicted to be located on the MHC alpha helices and to point "up" towards the TCR. We find that very limited changes (even a single amino acid) in either a CDR3 loop of the TCR or in a contact residue of the antigenic peptide can have a profound effect on relatively distant TCR/MHC interactions. The extent of these effects can be as great as that observed between T cells bearing entirely different TCRs and recognizing different peptides. We also find that superantigen presentation entails a distinct mode of TCR/MHC interaction compared with peptide presentation. These data suggest that TCR/MHC contacts can be made in a variety of ways between the same TCR and MHC, with the final configuration apparently dominated by the antigen. These observations suggest a molecular basis for recent reports in which either peptide analogues or superantigens trigger distinct pathways of T cell activation.

MeSH Terms
Amino Acid Sequence Animals Antigen-Presenting Cells/immunology,metabolism Antigens/immunology CHO Cells Cell Line Cricetinae Cytochrome c Group/immunology Enterotoxins/immunology Histocompatibility Antigens Class II/genetics,immunology,metabolism Hybridomas Molecular Sequence Data Mutation Peptides/immunology Receptors, Antigen, T-Cell/chemistry,metabolism Receptors, Antigen, T-Cell, alpha-beta/immunology,metabolism Staphylococcus aureus/immunology T-Lymphocytes/immunology,metabolism
Chemicals
Antigens Cytochrome c Group Enterotoxins Histocompatibility Antigens Class II I-E-antigen Peptides Receptors, Antigen, T-Cell Receptors, Antigen, T-Cell, alpha-beta enterotoxin A, Staphylococcal
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Ehrich E W
Department of Microbiology and Immunology, Stanford University School of Medicine, California 94305.
Devaux B
Rock E P
Jorgensen J L
Davis M M
Chien Y H
References (43)
43 references, click to expand
  1. T lymphocyte response to bacteriophage lambda repressor cI protein. Recognition of the same peptide presented by Ia molecules of different haplotypes.
    J Immunol. 1987 Dec 15;139(12):3973-80 PMID: 2961803
  2. Crystal structures of two viral peptides in complex with murine MHC class I H-2Kb.
    Science. 1992 Aug 14;257(5072):919-27 PMID: 1323877
  3. The biologic activity of anti-T cell receptor V region monoclonal antibodies is determined by the epitope recognized.
    J Immunol. 1988 Feb 15;140(4):1081-8 PMID: 2449495
  4. A hypothetical model of the foreign antigen binding site of class II histocompatibility molecules.
    Nature. 1988 Apr 28;332(6167):845-50 PMID: 3258651
  5. Evidence that multiple residues on both the alpha-helices of the class I MHC molecule are simultaneously recognized by the T cell receptor.
    Cell. 1988 Jul 1;54(1):47-56 PMID: 3260136
  6. Direct evidence for functional self-protein/Ia-molecule complexes in vivo.
    Proc Natl Acad Sci U S A. 1988 Jul;85(14):5220-3 PMID: 2839836
  7. T cell receptor gene usage in the response to lambda repressor cI protein. An apparent bias in the usage of a V alpha gene element.
    J Exp Med. 1988 Sep 1;168(3):1081-97 PMID: 2971753
  8. The outline structure of the T-cell alpha beta receptor.
    EMBO J. 1988 Dec 1;7(12):3745-55 PMID: 3208747
  9. Signal transduction by receptors with tyrosine kinase activity.
    Cell. 1990 Apr 20;61(2):203-12 PMID: 2158859
  10. Amino acid substitutions in the first complementarity-determining region of a murine T-cell receptor alpha chain affect antigen-major histocompatibility complex recognition.
    J Biol Chem. 1990 May 25;265(15):8842-6 PMID: 2140363
  11. Restricted V-(D)-J junctional regions in the T cell response to lambda-repressor. Identification of residues critical for antigen recognition.
    J Immunol. 1990 Jun 15;144(12):4851-6 PMID: 1693642
  12. Activation of polyphosphoinositide hydrolysis in T cells by H-2 alloantigen but not MLS determinants.
    Science. 1990 Jul 13;249(4965):171-4 PMID: 2164711
  13. The alpha 1 domain of the HLA-DR molecule is essential for high-affinity binding of the toxic shock syndrome toxin-1.
    Nature. 1990 Aug 2;346(6283):474-6 PMID: 2377209
  14. Expression of T cell antigen receptor heterodimers in a lipid-linked form.
    Science. 1990 Aug 10;249(4969):677-9 PMID: 1696397
  15. HLA-DR alleles differ in their ability to present staphylococcal enterotoxins to T cells.
    J Exp Med. 1990 Sep 1;172(3):709-17 PMID: 2117633
  16. Superantigens interact with MHC class II molecules outside of the antigen groove.
    Cell. 1990 Sep 21;62(6):1115-21 PMID: 2401011
  17. Degenerate binding of immunogenic peptides to HLA-DR proteins on B cell surfaces.
    Int Immunol. 1990;2(5):443-51 PMID: 1707655
  18. Expression of a class II major histocompatibility complex (MHC) heterodimer in a lipid-linked form with enhanced peptide/soluble MHC complex formation at low pH.
    J Exp Med. 1991 Jul 1;174(1):219-28 PMID: 1829108
  19. Conventional antigen and superantigen may be coupled to distinct and cooperative T-cell activation pathways.
    Proc Natl Acad Sci U S A. 1991 Oct 1;88(19):8705-9 PMID: 1681539
  20. Superantigen staphylococcal enterotoxin B-induced T-helper cell activation is independent of CD4 molecules and phosphatidylinositol hydrolysis.
    Proc Natl Acad Sci U S A. 1992 Sep 1;89(17):8035-9 PMID: 1355602
  21. T cell growth factor: parameters of production and a quantitative microassay for activity.
    J Immunol. 1978 Jun;120(6):2027-32 PMID: 307029
  22. Hybridoma cell lines secreting monoclonal antibodies to mouse H-2 and Ia antigens.
    J Immunol. 1980 Feb;124(2):533-40 PMID: 7188699
  23. Monoclonal antibody against an Ir gene product?
    J Exp Med. 1980 Oct 1;152(4):1085-101 PMID: 6158546
  24. Clonal analysis of B- and T-cell responses to Ia antigens. I. Topology of epitope regions on I-Ak and I-Ek molecules analyzed with 35 monoclonal alloantibodies.
    Immunogenetics. 1981 Dec;14(6):481-95 PMID: 6976317
  25. The T lymphocyte response to cytochrome c. IV. Distinguishable sites on a peptide antigen which affect antigenic strength and memory.
    J Immunol. 1983 Jul;131(1):319-24 PMID: 6190913
  26. Monoclonal antibodies against the antigen receptor on a cloned T-cell hybrid.
    Proc Natl Acad Sci U S A. 1983 Nov;80(22):6972-6 PMID: 6316339
  27. Monoclonal anti-Ia murine alloantibodies crossreactive with the Ia-homologues of other mammalian species including humans.
    Transplantation. 1983 Dec;36(6):712-8 PMID: 6581642
  28. Correlations between T-cell specificity and the structure of the antigen receptor.
    Nature. 1986 May 15-21;321(6067):219-26 PMID: 3012351
  29. Efficient cell surface expression of class II MHC molecules in the absence of associated invariant chain.
    J Exp Med. 1986 Nov 1;164(5):1478-89 PMID: 3464691
  30. Functionally distinct agretopic and epitopic sites. Analysis of the dominant T cell determinant of moth and pigeon cytochromes c with the use of synthetic peptide antigens.
    J Immunol. 1987 Sep 1;139(5):1578-88 PMID: 2442249
  31. Antigen recognition properties of mutant V beta 3+ T cell receptors are consistent with an immunoglobulin-like structure for the receptor.
    J Exp Med. 1993 Jan 1;177(1):119-25 PMID: 8380294
  32. The basics of binding: mechanisms of antigen recognition and mimicry by antibodies.
    Curr Opin Immunol. 1993 Feb;5(1):50-5 PMID: 8452674
  33. Separation of IL-4 production from Th cell proliferation by an altered T cell receptor ligand.
    Science. 1991 May 31;252(5010):1308-10 PMID: 1833816
  34. A single amino acid change in a myelin basic protein peptide confers the capacity to prevent rather than induce experimental autoimmune encephalomyelitis.
    Proc Natl Acad Sci U S A. 1991 Nov 1;88(21):9633-7 PMID: 1719536
  35. Identification of the staphylococcal enterotoxin A superantigen binding site in the beta 1 domain of the human histocompatibility antigen HLA-DR.
    Proc Natl Acad Sci U S A. 1991 Nov 15;88(22):9954-8 PMID: 1946464
  36. Physical association of CD4 with the T cell receptor.
    J Immunol. 1992 Feb 1;148(3):678-88 PMID: 1370513
  37. Mapping T-cell receptor-peptide contacts by variant peptide immunization of single-chain transgenics.
    Nature. 1992 Jan 16;355(6357):224-30 PMID: 1309938
  38. Antigen analog-major histocompatibility complexes act as antagonists of the T cell receptor.
    Cell. 1992 Feb 21;68(4):625-34 PMID: 1739971
  39. Structural evidence for induced fit as a mechanism for antibody-antigen recognition.
    Science. 1992 Feb 21;255(5047):959-65 PMID: 1546293
  40. Intercellular communication and cell-cell adhesion.
    Science. 1992 Mar 27;255(5052):1671-7 PMID: 1313187
  41. Functional analysis of the antigen binding site on the T cell receptor alpha chain.
    J Exp Med. 1992 Jun 1;175(6):1553-63 PMID: 1588281
  42. An MHC interaction site maps to the amino-terminal half of the T cell receptor alpha chain variable domain.
    Cell. 1992 Jun 12;69(6):999-1009 PMID: 1318787
  43. Rapid and efficient site-specific mutagenesis without phenotypic selection.
    Methods Enzymol. 1987;154:367-82 PMID: 3323813
Article Info
Journal
The Journal of experimental medicine
Abbr.
J Exp Med
ISSN
0022-1007
Published
1993-08-01
Pages
713-22
Language
English
Region
United States
NLM ID
2985109R
PMCID
PMC2191102
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]